OR WAIT null SECS
March 18, 2019
Findings from the Los Angeles Biomedical Research Institute could enable a new generation of anti-infectives.
The companies announced a collaboration to jointly discover and develop treatments to address unmet medical needs in a specific neurological disease.
March 11, 2019
Process optimization improves process mass intensity, reduces environmental impact, and improves cycle time for bio/pharmaceutical processes.
February 21, 2019
Mustang intends to combine an oncolytic virus with an interleukin-13 Rα2-(IL13Rα2)-specific chimeric antigen receptor to potentially enhance efficacy in treating glioblastoma multiforme.
February 15, 2019
The partners will collaborate on the development and commercialization of a B-cell maturation antigen-targeting immunotherapeutic for treating multiple myeloma.
February 14, 2019
The multi-year agreement will give Novartis access to AbCellera’s expertise and state-of-the-art antibody discovery technology for up to ten clinically-relevant disease targets.
February 07, 2019
A study funded by the National Institutes of Health has created a virtual library expected to expand the availability of “make-on-demand” molecules for drug discovery.
February 01, 2019
Tech transfer is key to succession advancing biopharmaceutical pipeline products from research to preclinical.
Drug developers must understand the complex bioanalytical assays for cell- and gene-therapy drug development programs and ensure that partners have the specialized expertise needed for complex therapeutic classes.
January 11, 2019
Researchers at the University of Delaware have made a step forward in gene therapy by engineering microparticles that deliver gene-regulating material to hematopoietic stem and progenitor cells, which live deep in bone marrow and direct the formation of blood cells.